Home Regeneron skids on shortfall in Eylea sales
 

Keywords :   


Regeneron skids on shortfall in Eylea sales

2014-11-05 00:27:56| Biotech - Topix.net

Regeneron Pharmaceuticals Inc. tumbled by more than $21 a share in morning trade Tuesday after the drug maker surprised investors with disappointing sales of a key product and reported third-quarter earnings that fell below forecasts. stumbled from grace as analysts said some of the air appears to be seeping from expectations for the company's blockbuster eye drug, Eylea.

Tags: sales shortfall skids regeneron

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
28.11SCR
28.1146
28.11BOSS OD-2 TURBO Over Drive
28.11/ Pulling the Plug
28.11
28.1110
28.112.5 120
28.11MSV-R
More »